Correlation Between Karyopharm Therapeutics and Dyadic International
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Dyadic International, you can compare the effects of market volatilities on Karyopharm Therapeutics and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Dyadic International.
Diversification Opportunities for Karyopharm Therapeutics and Dyadic International
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Karyopharm and Dyadic is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Dyadic International go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Dyadic International
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Dyadic International. But the stock apears to be less risky and, when comparing its historical volatility, Karyopharm Therapeutics is 1.29 times less risky than Dyadic International. The stock trades about -0.06 of its potential returns per unit of risk. The Dyadic International is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 158.00 in Dyadic International on September 25, 2024 and sell it today you would earn a total of 19.00 from holding Dyadic International or generate 12.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Dyadic International
Performance |
Timeline |
Karyopharm Therapeutics |
Dyadic International |
Karyopharm Therapeutics and Dyadic International Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Dyadic International
The main advantage of trading using opposite Karyopharm Therapeutics and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Dyadic International vs. Fate Therapeutics | Dyadic International vs. Caribou Biosciences | Dyadic International vs. Karyopharm Therapeutics | Dyadic International vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |